Bexxar (Corixa Corp) en es it fr

Bexxar (Corixa Corp) Brand names, Bexxar (Corixa Corp) Analogs

Bexxar (Corixa Corp) Brand Names Mixture

  • No information avaliable

Bexxar (Corixa Corp) Chemical_Formula

C6416H9874N1688O1987S44

Bexxar (Corixa Corp) RX_link

http://www.rxlist.com/cgi/generic3/bexxar.htm

Bexxar (Corixa Corp) fda sheet

Bexxar (Corixa Corp) msds (material safety sheet)

Bexxar (Corixa Corp) Synthesis Reference

No information avaliable

Bexxar (Corixa Corp) Molecular Weight

143859.7

Bexxar (Corixa Corp) Melting Point

61 oC (FAB fragment), 71 oC (whole mAb)-Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Bexxar (Corixa Corp) H2O Solubility

No information avaliable

Bexxar (Corixa Corp) State

Liquid

Bexxar (Corixa Corp) LogP

-0.414

Bexxar (Corixa Corp) Dosage Forms

Solution (IV Infusion)

Bexxar (Corixa Corp) Indication

For treatment of non-Hodgkin's lymphoma (CD20 positive, follicular)

Bexxar (Corixa Corp) Pharmacology

Bexxar binds to the CD20 antigen, which is predominantly expressed on mature B cells and on >90% of B-cell non-Hodgkin??™s lympohomas. The antibody leads to selective killing of B-cells.

Bexxar (Corixa Corp) Absorption

No information avaliable

Bexxar (Corixa Corp) side effects and Toxicity

No information avaliable

Bexxar (Corixa Corp) Patient Information

No information avaliable

Bexxar (Corixa Corp) Organisms Affected

Humans and other mammals